Dopamine beta hydroxylase deficiency
Other Names for this Disease
- Dopamine beta-hydroxylase deficiency
- Dopamine beta-hydroxylase deficiency, congenital
- Noradrenaline deficiency
- Norepinephrine deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.
- ClinicalTrials.gov lists trials that are studying or have studied Dopamine beta hydroxylase deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
(Chelsea Therapeutics, Inc.)
The FDA has approved this product to be used in this manner.
|Treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.|
|More Information about this product||Drug Information Portal|